Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stroke 1Neoplasms 1Myocardial Infarction 1Liver Neoplasms 1Liver Cirrhosis 1Colorectal Neoplasms 1Cardiovascular Diseases 1

Interventions

Gonadotropin-Releasing Hormone 2xinmailong 1palbociclib 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Vitamin B 6 1Vitamin B 12 1Testosterone 1Rivaroxaban 1Progesterone 1Genetic Testing 1Folic Acid 1Estradiol 1DNA 1Cardiovascular Agents 1Blood Specimen Collection 1Antineoplastic Agents 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cardiovascular Diseases × Vitamin B 6 × Clear all
NCT00106886 2005-09-20

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

McMaster University

Phase 4 Unknown
5,000 enrolled

Cardiovascular Diseases, Myocardial Infarction, Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡